J.Safra Asset Management Corp
Position in IDXX — Idexx Laboratories Inc /De
CIK 1535293
NEW YORK, NY
Position in IDXX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$25,269
-$1,701 QoQ
Shares Held
48
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,135
of 1,286 holders
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J.Safra Asset Management Corp holds $2,979,027 across 13 Diagnostics & Research names. IDXX ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
4,621 | $979,420 | |
| 2 | LH |
Labcorp Holdings Inc.
|
2,421 | $677,880 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
3,292 | $636,080 | |
| 4 | DHR |
Danaher Corp /De/
|
1,600 | $304,768 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
516 | $258,701 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
This page
|
48 | $25,269 | |
| 7 | A |
Agilent Technologies, Inc.
|
159 | $21,119 | |
| 8 | NTRA |
Natera, Inc.
|
67 | $18,187 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,269 | 48 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $26,970 | 48 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $32,473 | 48 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $30,666 | 48 | Shares | Sole | 2025-10-29 | |
| 2024-12-31 | $16,537 | 40 | Shares | Sole | 2025-02-06 | |
| 2022-09-30 | $651 | 2 | Shares | Sole | 2022-11-07 | |
| No filing history on record for this holder in this stock. | ||||||